ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival : Skin & Allergy News
Links shared publicly online about this topic.
- 238total visits
ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival : Skin & Allergy News
Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s
View full resource at skinandallergynews.com
Tags: Allergies, Dermatology, Skin, Cancer, Skin Cancer, Melanoma, News
Most Recently Shared on June 6, 2011 at 2:03 pm By:
ASCO: Ipilimumab Plus Dacarbazine Prolongs Metastatic Melanoma Survival http://tinyurl.com/6h5577v
Advertisement
